Showing results (111-120 of 142) with videos related to
Sort By:
Pageof 15
Nature Medicine|November 14, 2018
Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemiaDaniel A Pollyea, Brett M Stevens, Courtney L Jones, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2018
Dasatinib in Pediatric Patients With Chronic Myeloid Leukemia in Chronic Phase: Results From a Phase II TrialLia Gore, Pamela R Kearns, Maria Lucia de Martino, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2014
Phase I study of oral rigosertib (ON 01910.Na), a dual inhibitor of the PI3K and Plk1 pathways, in adult patients with advanced solid malignanciesDaniel W Bowles, Jennifer R Diamond, Elaine T Lam, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2013
Multicenter phase I trial of the mitogen-activated protein kinase 1/2 inhibitor BAY 86-9766 in patients with advanced cancerColin D Weekes, Daniel D Von Hoff, Alex A Adjei, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 3, 2017
Broadening Eligibility Criteria to Make Clinical Trials More Representative: American Society of Clinical Oncology and Friends of Cancer Research Joint Research StatementEdward S Kim, Suanna S Bruinooge, Samantha Roberts, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2016
Phase I/Phase II Study of Blinatumomab in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic LeukemiaArend von Stackelberg, Franco Locatelli, Gerhard Zugmaier, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 5, 2020
Impact of Intrathecal Triple Therapy Versus Intrathecal Methotrexate on Disease-Free Survival for High-Risk B-Lymphoblastic Leukemia: Children's Oncology Group Study AALL1131Wanda L Salzer, Michael J Burke, Meenakshi Devidas, et al.European Journal of Cancer (Oxford, England : 1990)|March 15, 2022
ACCELERATE - Five years accelerating cancer drug development for children and adolescentsAndrew D J Pearson, Susan L Weiner, Peter C Adamson, et al.Pediatric Blood & Cancer|August 22, 2022
Nelarabine, etoposide, and cyclophosphamide in relapsed pediatric T-acute lymphoblastic leukemia and T-lymphoblastic lymphoma (study T2008-002 NECTAR)James A Whitlock, Jemily Malvar, Luciano Dalla-Pozza, et al.The Lancet. Gastroenterology & Hepatology|July 14, 2019
Safety and activity of ivosidenib in patients with IDH1-mutant advanced cholangiocarcinoma: a phase 1 studyMaeve A Lowery, Howard A Burris, Filip Janku, et al.Pageof 15